EP0315574A3
(de)
|
1987-11-05 |
1990-08-22 |
Hoechst Aktiengesellschaft |
Renin-Inhibitoren
|
US5023236A
(en)
|
1988-04-07 |
1991-06-11 |
Corvas, Inc. |
Factor VII/VIIA active site inhibitors
|
DE3827340A1
(de)
|
1988-08-12 |
1990-02-15 |
Hoechst Ag |
Verwendung von (alpha)-aminoboronsaeure-derivaten zur prophylaxe und behandlung von viruserkrankungen
|
US5225402A
(en)
|
1989-02-10 |
1993-07-06 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives
|
IE910713A1
(en)
|
1990-03-05 |
1991-09-11 |
Cephalon Inc |
Chymotrypsin-like proteases
|
GB9017694D0
(en)
|
1990-08-13 |
1990-09-26 |
Sandoz Ltd |
Improvements in or relating to organic chemistry
|
GB9024129D0
(en)
|
1990-11-06 |
1990-12-19 |
Thrombosis Research Trust |
Inhibitors and substrates of thrombin
|
US5712267A
(en)
|
1991-06-04 |
1998-01-27 |
Sankyo Company,. Limited |
Carbapenem derivatives, their preparation and their use as antibiotics
|
JP2668003B2
(ja)
|
1992-06-12 |
1997-10-27 |
ファイザー インク. |
ヒトの心臓キマーゼを含むアンギオテンシンiキマーゼに関する阻害剤
|
US5208313A
(en)
|
1992-07-16 |
1993-05-04 |
Surface Coatings, Inc. |
Waterproof breathable polyurethane membranes and porous substrates protected therewith
|
US5658885A
(en)
|
1993-04-27 |
1997-08-19 |
The Dupont Merck Pharmaceutical Company |
Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes
|
IL109319A0
(en)
|
1993-04-27 |
1994-07-31 |
Du Pont Merck Pharma |
Amidino and guanidino substituted boronic acid compounds
|
US5672582A
(en)
|
1993-04-30 |
1997-09-30 |
Merck & Co., Inc. |
Thrombin inhibitors
|
ES2184763T3
(es)
|
1993-04-30 |
2003-04-16 |
Merck & Co Inc |
Inhibidores de trombina.
|
KR100316865B1
(ko)
|
1993-10-01 |
2002-11-29 |
메렐 파마슈티칼스 인크. |
베타-아밀로이드단백질생성억제제
|
IL111176A0
(en)
|
1993-10-07 |
1994-12-29 |
Du Pont Merck Pharma |
Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them
|
IL111175A0
(en)
|
1993-10-07 |
1994-12-29 |
Du Pont Merck Pharma |
Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
|
GB9401483D0
(en)
|
1994-01-26 |
1994-03-23 |
Sandoz Ltd |
Organic compounds
|
US6083903A
(en)
|
1994-10-28 |
2000-07-04 |
Leukosite, Inc. |
Boronic ester and acid compounds, synthesis and uses
|
CA2200964A1
(en)
|
1994-11-24 |
1996-05-30 |
Takashi Sohda |
Alpha-ketoamide derivatives as cathepsin l inhibitor
|
US5919765A
(en)
|
1995-06-07 |
1999-07-06 |
Cor Therapeutics, Inc. |
Inhibitors of factor XA
|
TW442452B
(en)
|
1996-03-01 |
2001-06-23 |
Akzo Nobel Nv |
Serine protease inhibitors having an alkynylamino side chain
|
TW523513B
(en)
|
1996-03-01 |
2003-03-11 |
Akzo Nobel Nv |
Serine protease inhibitors
|
UA66767C2
(uk)
|
1996-10-18 |
2004-06-15 |
Вертекс Фармасьютикалс Інкорпорейтед |
Інгібітори серин-протеаз, фармацевтична композиція, спосіб інгібування активності та спосіб лікування або профілактики вірусної інфекції гепатиту с
|
GB9623908D0
(en)
|
1996-11-18 |
1997-01-08 |
Hoffmann La Roche |
Amino acid derivatives
|
JP4452401B2
(ja)
|
1997-08-11 |
2010-04-21 |
ベーリンガー インゲルハイム (カナダ) リミテッド |
C型肝炎ウイルス阻害ペプチドアナログ
|
DE19746468A1
(de)
|
1997-10-21 |
1999-04-22 |
Henkel Kgaa |
Haar-Masara
|
AU5290499A
(en)
|
1998-08-03 |
2000-02-28 |
Novartis Ag |
Human htra serine protease
|
JP2003506016A
(ja)
|
1999-02-19 |
2003-02-18 |
ザ ユニヴァーシティー オブ アイオワ リサーチ ファンデーション |
動脈壁破裂障害のための診断剤および治療剤
|
WO2001002424A2
(en)
|
1999-07-07 |
2001-01-11 |
Du Pont Pharmaceuticals Company |
Peptide boronic acid inhibitors of hepatitis c virus protease
|
AU2002222933A1
(en)
|
2000-07-13 |
2002-01-30 |
Millennium Pharamaceuticals, Inc. |
Inhibitors of factor xa
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
EP1303487A4
(en)
|
2000-07-21 |
2005-11-23 |
Schering Corp |
NOVEL PEPTIDES AS INHIBITORS OF THE NS3 SERINE PROTEASE OF HEPATITIS C VIRUS
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
SI1385870T1
(sl)
|
2000-07-21 |
2010-08-31 |
Schering Corp |
Peptidi kot NS3-serin proteazni inhibitorji virusa hepatitisa C
|
AU2001280187A1
(en)
|
2000-08-28 |
2002-03-13 |
Toray Industries, Inc. |
Cyclic amine derivatives
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
US6846806B2
(en)
|
2000-10-23 |
2005-01-25 |
Bristol-Myers Squibb Company |
Peptide inhibitors of Hepatitis C virus NS3 protein
|
FR2816509B1
(fr)
|
2000-11-15 |
2004-02-06 |
Sod Conseils Rech Applic |
Association d'inhibiteurs de calpaine et de piegeurs des formes reactives de l'oxygene
|
US7172874B2
(en)
|
2001-04-30 |
2007-02-06 |
The Cleveland Clinic Foundation |
Diagnostic methods for age related macular degeneration
|
US7244815B2
(en)
|
2001-05-23 |
2007-07-17 |
The Curators Of The University Of Missouri |
Attachment and elaboration strategies for inverse peptide synthesis
|
WO2002094857A1
(en)
|
2001-05-23 |
2002-11-28 |
The Curators Of The University Of Missouri |
Inverse solid phase synthesis of peptides
|
US6933290B2
(en)
|
2001-05-30 |
2005-08-23 |
Novartis Ag |
2-{N-(2-amino-3-(heteroaryl or aryl)propionyl)-aminoacyl}-amino}-alkylboronic acid derivatives
|
CA2481369C
(en)
|
2002-04-11 |
2012-07-10 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
|
PL215228B1
(pl)
|
2002-05-20 |
2013-11-29 |
Bristol Myers Squibb Co |
Zwiazki tripeptydowe, ich zastosowanie i kompozycja farmaceutyczna je zawierajaca oraz jej zastosowanie
|
AU2003265264A1
(en)
|
2002-07-09 |
2004-01-23 |
Point Therapeutics, Inc. |
Methods and compositions relating to isoleucine boroproline compounds
|
KR20050057294A
(ko)
|
2002-09-09 |
2005-06-16 |
트라이젠 리미티드 |
보론산 염, 및 혈전증의 치료를 위한 그것의 용도
|
US20050119226A1
(en)
|
2003-09-09 |
2005-06-02 |
Trigen Limited |
Methods for synthesizing organoboronic compounds and products thereof
|
US20050282757A1
(en)
|
2002-09-09 |
2005-12-22 |
Trigen Limited |
Peptide boronic acid compounds useful in anticoagulation
|
US20050176651A1
(en)
|
2002-09-09 |
2005-08-11 |
Trigen Limited |
Peptide boronic acids useful in making salts thereof
|
MXPA05007394A
(es)
|
2003-01-08 |
2005-09-12 |
Chiron Corp |
Agentes antibacterianos.
|
WO2004103270A2
(en)
|
2003-04-02 |
2004-12-02 |
Suntory Pharmaceutical Research Laboratories Llc |
Compounds and methods for treatment of thrombosis
|
US20050090450A1
(en)
|
2003-04-11 |
2005-04-28 |
Farmer Luc J. |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
WO2004113365A2
(en)
*
|
2003-06-05 |
2004-12-29 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c serine protease tri-peptide inhibitors
|
US7273851B2
(en)
|
2003-06-05 |
2007-09-25 |
Enanta Pharmaceuticals, Inc. |
Tri-peptide hepatitis C serine protease inhibitors
|
TW200523270A
(en)
|
2003-07-18 |
2005-07-16 |
Vertex Pharma |
Inhibitors of serine proteases, particularly HCV ns3-ns4a protease
|
TWI359147B
(en)
|
2003-09-05 |
2012-03-01 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hcv n
|
WO2005028502A1
(en)
|
2003-09-18 |
2005-03-31 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
US7365092B2
(en)
|
2003-10-10 |
2008-04-29 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
RU2006131043A
(ru)
|
2004-01-30 |
2008-03-10 |
Шеринг Акциенгезельшафт (De) |
Соединения силинана в качестве ингибиторов цистеиновой протеазы
|
US7683033B2
(en)
|
2004-02-04 |
2010-03-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
AU2005216970B2
(en)
|
2004-02-23 |
2011-07-07 |
Trustees Of Tufts College |
Inhibitors of dipeptidylpeptidase IV for regulating glucose metabolism
|
GB0405280D0
(en)
|
2004-03-09 |
2004-04-21 |
Trigen Ltd |
Compounds
|
GB0405267D0
(en)
|
2004-03-09 |
2004-04-21 |
Trigen Ltd |
Compounds
|
GB0405272D0
(en)
|
2004-03-09 |
2004-04-21 |
Trigen Ltd |
Compounds
|
MXPA06012391A
(es)
|
2004-04-30 |
2007-01-31 |
Theraptosis S A |
Inhibidores de caspasa-2 y sus aplicaciones biologicas.
|
KR100984459B1
(ko)
|
2004-07-02 |
2010-09-29 |
제넨테크, 인크. |
Iap의 억제제
|
FR2873695A1
(fr)
|
2004-07-30 |
2006-02-03 |
Palumed Sa |
Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
|
WO2006021409A1
(en)
|
2004-08-25 |
2006-03-02 |
Santhera Pharmaceuticals (Schweiz) Ag |
Alpha-keto carbonyl calpain inhibitors
|
JP2008510759A
(ja)
|
2004-08-25 |
2008-04-10 |
サンセラ ファーマシューティカルズ (シュバイツ) アーゲー |
α−ケトカルボニルカルパイン阻害剤
|
WO2006059082A1
(en)
|
2004-11-30 |
2006-06-08 |
Trigen Limited |
Oxidised lipids as reversal agents for boronic acid drugs
|
WO2006059083A1
(en)
|
2004-11-30 |
2006-06-08 |
Trigen Limited |
Neutralising agents for boronic acid drugs
|
NZ595305A
(en)
|
2005-02-14 |
2013-06-28 |
Univ Iowa Res Found |
Methods and reagents for treatment and diagnosis of age-related macular degeneration
|
ZA200707420B
(en)
*
|
2005-02-14 |
2009-04-29 |
Univ Iowa Res Found |
Methods and reagents for treatment and diagnosis of age-related macular degeneration
|
WO2006113942A2
(en)
|
2005-04-20 |
2006-10-26 |
Schering Corporation |
Method of inhibiting cathepsin activity
|
US20060275366A1
(en)
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Controlled-release formulation
|
US20060276406A1
(en)
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Methods of treating hepatitis C virus
|
US20060276407A1
(en)
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Methods of treating hepatitis C virus
|
US20060276405A1
(en)
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Methods for treating hepatitis C
|
US20070004635A1
(en)
|
2005-06-02 |
2007-01-04 |
Schering Corporation |
Method of treating interferon non-responders using HCV protease inhibitor
|
US7608592B2
(en)
|
2005-06-30 |
2009-10-27 |
Virobay, Inc. |
HCV inhibitors
|
WO2007016476A2
(en)
|
2005-08-01 |
2007-02-08 |
Phenomix Corporation |
Hepatitis c serine protease inhibitors and uses therefor
|
EP2029153A2
(en)
*
|
2006-01-27 |
2009-03-04 |
Phenomix Corporation |
Hepatitis c serine protease inhibitors and uses therefor
|
WO2007095250A2
(en)
|
2006-02-13 |
2007-08-23 |
The Cleveland Clinic Foundation |
Compositions and methods for inhibiting optic nerve damage
|
US20070212865A1
(en)
|
2006-03-08 |
2007-09-13 |
Craig Amrine |
Method for planarizing vias formed in a substrate
|
JP5167244B2
(ja)
|
2006-04-11 |
2013-03-21 |
ノバルティス アーゲー |
Hcv/hiv阻害剤およびそれらの使用
|
WO2007120595A2
(en)
|
2006-04-11 |
2007-10-25 |
Novartis Ag |
Amines for the treatment of hcv
|
CL2007001630A1
(es)
|
2006-06-06 |
2008-02-08 |
Enanta Pharm Inc |
Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
|
WO2007146831A2
(en)
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
US20100056495A1
(en)
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
CA2658853A1
(en)
|
2006-07-26 |
2008-01-31 |
Yale University |
Diagnosis and treatment of age related macular degeneration
|
EP2081596A4
(en)
|
2006-10-06 |
2010-07-21 |
Univ Utah Res Found |
METHOD FOR DETECTING DISEASES AND PATHOLOGICAL DISEASES OF IL AND TREATMENT THEREOF
|
EP2913341A1
(en)
|
2006-12-22 |
2015-09-02 |
University of Utah Research Foundation |
Method of detecting ocular diseases and pathologic conditions and treatment of same
|
WO2008086053A1
(en)
|
2007-01-03 |
2008-07-17 |
Virobay, Inc. |
Hcv inhibitors
|
WO2008089485A2
(en)
|
2007-01-19 |
2008-07-24 |
The Cleveland Clinic Foundation |
Carboxyethylpyrrole compounds and methods of their production
|
WO2008103299A2
(en)
|
2007-02-16 |
2008-08-28 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for prognosing, detecting, and treating age-related macular degeneration
|
CA2679377A1
(en)
|
2007-02-26 |
2008-09-04 |
Achillion Pharmaceuticals, Inc. |
Tertiary amine substituted peptides useful as inhibitors of hcv replication
|
WO2008112801A1
(en)
|
2007-03-12 |
2008-09-18 |
Mayo Foundation For Medical Education And Research |
Macular degeneration
|
WO2009008913A2
(en)
|
2007-03-23 |
2009-01-15 |
Schering Corporation |
P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease
|
US20100105629A1
(en)
|
2007-03-23 |
2010-04-29 |
Bachovchin William W |
N-Substituted Peptidomimetic Inhibitors of Dipeptidylpeptidase IV
|
AU2008251425A1
(en)
|
2007-05-10 |
2008-11-20 |
Array Biopharma, Inc. |
Novel peptide inhibitors of hepatitis C virus replication
|
TW200911290A
(en)
|
2007-07-02 |
2009-03-16 |
Alcon Res Ltd |
RNAI-mediated inhibition of HTRA1 for treatment of macular degeneration
|
WO2009006473A2
(en)
|
2007-07-05 |
2009-01-08 |
Trustees Of Tufts College |
Pro-soft polypeptide proteasome inhibitors, and methods of use thereof
|
PL2178888T3
(pl)
|
2007-08-06 |
2012-11-30 |
Millennium Pharm Inc |
Inhibitory proteasomów
|
WO2009046405A2
(en)
|
2007-10-05 |
2009-04-09 |
University Of Utah Research Foundation |
Antibodies to htra1 and methods of using the same
|
US7683636B2
(en)
|
2007-10-26 |
2010-03-23 |
Honeywell International Inc. |
Structure for capacitive balancing of integrated relative humidity sensor
|
US20100303832A1
(en)
|
2007-11-01 |
2010-12-02 |
Hageman Gregory S |
Genes and polymorphisms associated with amd
|
PT2225261E
(pt)
|
2007-12-03 |
2016-06-09 |
Obe Therapy Biotechnology |
Inibidores boropeptídicos de enteropeptidase e suas utilizações no tratamento de obesidade, excesso de peso e/ou doenças associadas com um metabolismo anormal da gordura
|
US8193346B2
(en)
|
2007-12-06 |
2012-06-05 |
Enanta Pharmaceuticals, Inc. |
Process for making macrocyclic oximyl hepatitis C protease inhibitors
|
EA201001262A1
(ru)
|
2008-02-07 |
2011-04-29 |
Вайробей, Инк. |
Ингибиторы катепсина в
|
WO2009109860A2
(en)
|
2008-03-06 |
2009-09-11 |
Novartis Ag |
Mutant forms of chlamydia htra
|
CN101638414B
(zh)
|
2008-07-30 |
2014-01-08 |
江苏先声药物研究有限公司 |
肽硼酸及其酯类化合物、制备方法及其用途
|
AU2009282480B2
(en)
|
2008-08-11 |
2015-05-07 |
Children's Medical Center Corporation |
Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
|
AR075090A1
(es)
|
2008-09-29 |
2011-03-09 |
Millennium Pharm Inc |
Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
|
CA2740242A1
(en)
|
2008-11-05 |
2010-05-14 |
Genentech, Inc. |
Genetic polymorphisms in age-related macular degeneration
|
WO2010132459A2
(en)
|
2009-05-11 |
2010-11-18 |
Cleveland Clinic Foundation |
Biomarkers for assessment of age-related macular degeneration
|
CN101928329B
(zh)
|
2009-06-19 |
2013-07-17 |
北京大学 |
三肽硼酸(酯)类化合物、其制备方法和应用
|
WO2011053774A1
(en)
|
2009-10-30 |
2011-05-05 |
Alcon Research, Ltd. |
Single nucleotide polymorphisms and genes associated with age-related macular degeneration
|
CN102791687B
(zh)
*
|
2009-12-18 |
2015-02-11 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
US9365612B2
(en)
|
2010-01-29 |
2016-06-14 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Caspase inhibitors
|
MA34133B1
(fr)
|
2010-03-01 |
2013-04-03 |
Onyx Therapeutics Inc |
Composes pour inhibiteurs de l'immunoproteasome
|
US20110312996A1
(en)
|
2010-05-17 |
2011-12-22 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
WO2011156632A2
(en)
|
2010-06-09 |
2011-12-15 |
Georgetown University |
Compositions and methods of treatment for tumors in the nervous system
|
WO2012040242A1
(en)
|
2010-09-22 |
2012-03-29 |
Intermune, Inc. |
Substituted proline inhibitors of hepatitis c virus replication
|
WO2012078540A1
(en)
*
|
2010-12-08 |
2012-06-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modulating immune cell activity using cytokine-induced src homology 2 and/or high temperature requirement a-1
|
TWI617559B
(zh)
|
2010-12-22 |
2018-03-11 |
江蘇恆瑞醫藥股份有限公司 |
2-芳基咪唑并[1,2-b]嗒.2-苯基咪唑并[1,2-a]吡啶,和2-苯基咪唑并[1,2-a]吡衍生物
|
AU2012229067A1
(en)
|
2011-03-15 |
2013-10-31 |
University Of Utah Research Foundation |
Methods of diagnosing and treating Vascular Associated Maculopathy and symptoms thereof
|
CN102807607B
(zh)
|
2011-07-22 |
2013-10-23 |
爱博新药研发(上海)有限公司 |
抑制丙肝病毒的稠环杂环类化合物、其中间体及其应用
|
HUE060305T2
(hu)
|
2011-08-30 |
2023-02-28 |
Tufts College |
FAP-aktivált proteaszóma inhibitorok a szolid tumorok kezelésére
|
JP6532678B2
(ja)
|
2011-10-14 |
2019-06-19 |
ジェネンテック, インコーポレイテッド |
抗HtrA1抗体及び使用方法
|
WO2013059278A2
(en)
|
2011-10-17 |
2013-04-25 |
Enanta Pharmaceuticals, Inc. |
Hepatitis c virus inhibitors
|
US8549645B2
(en)
|
2011-10-21 |
2013-10-01 |
Mcafee, Inc. |
System and method for detection of denial of service attacks
|
WO2013123456A1
(en)
|
2012-02-16 |
2013-08-22 |
Rqx Pharmaceuticals, Inc. |
Linear peptide antibiotics
|
AU2013202580B2
(en)
|
2012-04-05 |
2014-08-14 |
Prince Henry's Institute Of Medical Research |
Antibodies to HtrA3
|
WO2014043558A1
(en)
|
2012-09-14 |
2014-03-20 |
University Of Utah Research Foundation |
Methods of predicting the development of amd based on chromosome 1 and chromosome 10
|
CN105378080A
(zh)
|
2013-05-01 |
2016-03-02 |
莱古路斯治疗法股份有限公司 |
用于调节mir-122的微小rna化合物和方法
|
WO2015042297A1
(en)
|
2013-09-20 |
2015-03-26 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Compounds for treating prostate can cancer
|
WO2015042447A1
(en)
|
2013-09-20 |
2015-03-26 |
Isis Pharmaceuticals, Inc. |
Targeted therapeutic nucleosides and their use
|
JP6337750B2
(ja)
|
2013-11-22 |
2018-06-06 |
小野薬品工業株式会社 |
化合物
|
MX2016006604A
(es)
|
2013-12-20 |
2016-09-08 |
Esteve Labor Dr |
Derivados de piperidina con actividad multimodal contra el dolor.
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
WO2016100555A1
(en)
*
|
2014-12-18 |
2016-06-23 |
Inception 4, Inc. |
Boronic acid derivatives and uses thereof
|
AR103742A1
(es)
*
|
2015-02-25 |
2017-05-31 |
Hoffmann La Roche |
Derivados de trifluorometilpropanamida
|
FR3034709B1
(fr)
|
2015-04-09 |
2017-04-14 |
Michelin & Cie |
Pneumatique muni d'un dispositif electronique
|
EP3294718B1
(en)
*
|
2015-05-11 |
2020-04-29 |
H. Hoffnabb-La Roche Ag |
New difluoroketamide derivatives
|
ES2870141T3
(es)
|
2015-10-30 |
2021-10-26 |
Hoffmann La Roche |
Anticuerpos anti-HtrA1 y procedimientos de uso de los mismos
|
JP2019507176A
(ja)
|
2016-03-04 |
2019-03-14 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
Htra1阻害剤としての新規ジフルオロケタミド誘導体
|
EP3423469A1
(en)
|
2016-03-04 |
2019-01-09 |
H. Hoffnabb-La Roche Ag |
New trifluoromethylpropanamide derivatives as htra1 inhibitors
|
KR102595723B1
(ko)
|
2016-06-21 |
2023-10-27 |
오리온 옵탈몰로지 엘엘씨 |
헤테로시클릭 프롤린아미드 유도체
|
US10730832B2
(en)
|
2016-06-21 |
2020-08-04 |
Orion Ophthalmology LLC |
Aliphatic prolinamide derivatives
|
JP7164521B2
(ja)
*
|
2016-06-21 |
2022-11-01 |
オリオン・オフサルモロジー・エルエルシー |
炭素環式プロリンアミド誘導体
|
TW201803990A
(zh)
|
2016-07-01 |
2018-02-01 |
赫孚孟拉羅股份公司 |
用於調節htra1表現之反股寡核苷酸
|
EP3484859B1
(en)
|
2016-07-18 |
2021-09-15 |
F. Hoffmann-La Roche AG |
New difluoroketamide derivatives as htra1 inhibitors
|
CN109563084A
(zh)
|
2016-08-23 |
2019-04-02 |
豪夫迈·罗氏有限公司 |
作为htra1抑制剂的新型三氟甲基丙酰胺衍生物
|
EP3504193A1
(en)
|
2016-08-23 |
2019-07-03 |
H. Hoffnabb-La Roche Ag |
New difluoroketamide derivatives as htra1 inhibitors
|
US11149067B2
(en)
|
2017-05-12 |
2021-10-19 |
Universität Duisburg-Essen |
Tailored cyclodepsipeptides as potent non-covalent serine protease inhibitors
|